产品详情
简单介绍：
Anti-C12ORF54抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-C12ORF54抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-C12ORF54
Cat. Number:
Anti-C12ORF54抗体KL-9952R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5% of the human genome. A number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, Anti-C12ORF54抗体SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The C12orf54 gene product has been provisionally designated C12orf54 pending further characterization.
Also known as:
MGC35033; C12orf54; Anti-C12ORF54抗体Chromosome 12 open reading frame 54; CL054_HUMAN; HSD 29; HSD 30; HSD29; Uncharacterized protein C12orf54.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C12ORF54.
●
Predicted Molecular Weight: 14kDa.
Storage:
Shipped at 4℃, StoreAnti-C12ORF54抗体 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-C12ORF54抗体dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C12ORF54抗体dilutions must be determined by the end user.
kl128Mu02 组织金属蛋白酶抑制因子2(TIMP2)多克隆抗体 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 2 (TIMP2)
kl129Mu02 组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)
kl130Mu02 组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)
kl131Mu02 转化生长因子β诱导蛋白(TGFβI)多克隆抗体 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl133Mu02 肿瘤坏死因子α(TNFα)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
kl134Mu02 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Mu02 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl136Mu01 肿瘤坏死因子受体超家族成员10A(TNFRSF10A)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10A (TNFRSF10A)
kl136Mu02 肿瘤坏死因子受体超家族成员10A(TNFRSF10A)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10A (TNFRSF10A)
kl139Mu02 肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl140Mu02 尿激酶型纤溶酶原激活因子(uPA)多克隆抗体 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl141Mu02 尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Mu02 细胞间粘附分子5(ICAM5)多克隆抗体 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl144Mu02 血管内皮生长因子B(VEGFB)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Mu02 血管内皮生长因子C(VEGFC)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl146Mu02 血管内皮生长因子D(VEGFD)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl147Mu02 脂联素受体1(ADIPOR1)多克隆抗体 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl149Mu02 Ⅳ型胶原α1(COL4α1)多克隆抗体 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu02 激肽释放酶3(KLK3)多克隆抗体 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl153Mu02 甲胎蛋白(αFP)多克隆抗体 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
